A revolutionary malaria treatment is to begin trials in Mozambique in healthy people. Along with their standard WHO vaccinations, 2000 newborn infants—and 600 pregnant women—will be given the anti-malarial drug sulfadoxine-pyrimethamine. In a smaller trial in Tanzania, the preventative treatment reduced the rate of clinical malaria by almost 60 per cent, and halved the rate of severe anaemia caused by malaria. Researchers from the Hospital Clinic of Barcelona now hope to confirm these findings.
To continue reading, today with our introductory offers
Advertisement
More from ¿ìè¶ÌÊÓƵ
Explore the latest news, articles and features
Popular articles
Trending ¿ìè¶ÌÊÓƵ articles
1
The best new science-fiction books of June 2026
2
Pancreatic cancer halted by virus injection in three patients
3
Does gravity create reality? A shocking path to a theory of everything
4
Glaciers in the 'roof of the world' have suddenly started melting
5
Q-Day could destroy bitcoin – and our retirement savings
6
How a radical new view of life could reveal its origin – and aliens
7
The ‘doomsday’ glacier’s giant ice shelf is about to break away
8
NASA plans a base on the moon spanning hundreds of square kilometres
9
Start-ups are racing to revolutionise mathematics with AI
10
Embryos made without sperm or eggs reveal why many pregnancies fail
